Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Studies that have evaluated the use of intravenous vitamin C in adults with sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown mixed results with respect to the risk of death and organ dysfunction. METHODS: In this randomized, placebo-controlled trial, we assigned adults who had been in the ICU for no longer than 24 hours, who had proven or suspected infection as the main diagnosis, and who were receiving a vasopressor to receive an infusion of either vitamin C (at a dose of 50 mg per kilogram of body weight) or matched placebo administered every 6 hours for up to 96 hours. The primary outcome was a composite of death or persistent organ dysfunction (defined by the use of vasopressors, invasive mechanical ventilation, or new renal-replacement therapy) on day 28. RESULTS: A total of 872 patients underwent randomization (435 to the vitamin C group and 437 to the control group). The primary outcome occurred in 191 of 429 patients (44.5%) in the vitamin C group and in 167 of 434 patients (38.5%) in the control group (risk ratio, 1.21; 95% confidence interval [CI], 1.04 to 1.40; P = 0.01). At 28 days, death had occurred in 152 of 429 patients (35.4%) in the vitamin C group and in 137 of 434 patients (31.6%) in the placebo group (risk ratio, 1.17; 95% CI, 0.98 to 1.40) and persistent organ dysfunction in 39 of 429 patients (9.1%) and 30 of 434 patients (6.9%), respectively (risk ratio, 1.30; 95% CI, 0.83 to 2.05). Findings were similar in the two groups regarding organ-dysfunction scores, biomarkers, 6-month survival, health-related quality of life, stage 3 acute kidney injury, and hypoglycemic episodes. In the vitamin C group, one patient had a severe hypoglycemic episode and another had a serious anaphylaxis event. CONCLUSIONS: In adults with sepsis receiving vasopressor therapy in the ICU, those who received intravenous vitamin C had a higher risk of death or persistent organ dysfunction at 28 days than those who received placebo. (Funded by the Lotte and John Hecht Memorial Foundation; LOVIT ClinicalTrials.gov number, NCT03680274.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review and meta-analysis of 2124 patients, with 1274 on pulmonary hypertension specific agents demonstrated only small quality of life benefits in patients with PH and IPF, thus there is insufficient evidence to support their widespread use [119].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [119]
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationAPACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts
Liu, V., Escobar, G. J., Greene, J. D., Soule, J., Whippy, A., Angus, D. C., & Iwashyna, T. J. (2014) · JAMA · doi:10.1001/jama.2014.5804 · Cited by 977
A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients
Heyland, D., Muscedere, J., Wischmeyer, P. E., Cook, D., Jones, G., Albert, M., Elke, G., Berger, M. M., & Day, A. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212722 · Cited by 904
Self-citationHydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Fowler, A. A., Truwit, J. D., Hite, R. D., Morris, P. E., DeWilde, C., Priday, A., Fisher, B., Thacker, L. R., Natarajan, R., Brophy, D. F., et al. (2019) · JAMA · doi:10.1001/jama.2019.11825 · Cited by 836
Research works printed but not linked: 1
- Kellum JA, Lameire N, Aspelin P, et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:Suppl 1:1-38.
Cited by
Items 101–200 of 354
Privšek, M., Strnad, M., & Markota, A. (2024) · Medicina · doi:10.3390/medicina60010103 · Cited by 13
“Several subsequent trials produced inconclusive results [26–29], all of which were conducted on patients with sepsis.”
ResultSubphenotypes and phenotypes to resolve sepsis heterogeneity: hype or hope?
Kalil, A. C., Póvoa, P. M. S. R., & Léone, M. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07828-x · Cited by 15
Hwang, K. Y., Phoon, P. H. Y., & Hwang, N. C. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.12.016 · Cited by 11
Management of vasoplegic shock
Mistry, R. N., & Winearls, J. (2024) · BJA Education · doi:10.1016/j.bjae.2024.10.004 · Cited by 13
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock
Albertson, T. E., Chenoweth, J., Lewis, J., Pugashetti, J. V., Sandrock, C. E., & Morrissey, B. M. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2110067 · Cited by 13
Intravenous vitamin C for vasoplegia: A double-blinded randomised clinical trial (VALENCIA trial)
Anstey, M., Aljeaidi, M. S., Palmer, R. N., Jacques, A., Mevavala, B. V., Litton, E., & Wibrow, B. A. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154369 · Cited by 10
The Management of Severe Sepsis and Septic Shock: A Novel Update and Bedside Reference Guide
Carvey, M., & Glauser, J. M. (2025) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-025-00310-4 · Cited by 18
“The study found that patients who were administered vitamin C had a higher risk of death at 28 days compared to those receiving a placebo [17].”
Zhang, X., Ji, W., Deng, X., & Bo, L. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01319-5 · Cited by 11
Nutrition after severe burn injury
Rousseau, A., Pantet, O., & Heyland, D. K. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000904 · Cited by 21
“Of note, a potential harm of high doses of intravenous vitamin C (50mg/kg/6h during 96h) was prospectively observed in a large cohort of septic adults receiving vasopressors in a critical care unit [20].”
BackgroundSelf-citationLOVIT or leave it: The vitamin C debate continues
Lankadeva, Y. R., Lane, D. J. R., Ow, C. P. C., Story, D., Plummer, M. P., & May, C. N. (2023) · Critical Care and Resuscitation · doi:10.1016/j.ccrj.2023.05.001 · Cited by 9
“9 In contrast, sodium ascorbate demonstrates a relatively acid-base balanced pH range (6.5 e 7.2) (Fig.”
InfluentialThe effect of vitamin C in adults with sepsis: a meta-analysis of randomized controlled trials
Luo, X., Zhu, Y., Zhang, R., Zhu, J., Kuang, H., Shao, Y., Guo, X., & Ning, B. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1244484 · Cited by 10
Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis
Rozemeijer, S., Hemilä, H., van Baaren, M., & de Man, A. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03459-6 · Cited by 10
“The recently published LOVIT-trial investigated the effect of 4-day vitamin C administration in septic patients [68].”
BackgroundRestrictive fluid therapy and high-dose vitamin C in sepsis
Plummer, M. P., & Bellomo, R. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00609-5 · Cited by 9
Effect of intravenous vitamin C on adult septic patients: a systematic review and meta-analysis
Liang, H., Mu, Q., Sun, W., Liu, L., Qiu, S., Xu, Z., Cui, Y., Yan, Y., & Sun, T. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1211194 · Cited by 10
“Furthermore, some randomized controlled trials (RCTs) have further confirmed the therapeutic efficacy of IVVC for sepsis compared to placebo (15–17).”
BackgroundMethodInfluentialYong, S., Suping, L., Peng, Z., Dong, L., & Qing, W. (2024) · Medicine · doi:10.1097/md.0000000000037420 · Cited by 9
Stoppe, C., Hill, A., Cancio, L. C., Day, A. G., Pruskowski, K. A., Turgeon, A. F., Pham, T. N., Bélisle, S. J., Martínez‐Jiménez, M. A., Limper, U., et al. (2026) · JAMA · doi:10.1001/jama.2026.10616 · Cited by 12
Self-citationThe effects of antioxidant supplementation on short-term mortality in sepsis patients
Pei, H., Qu, J., Chen, J., Zhang, Y.-L., Zhang, M., Zhao, G., & Lu, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29156 · Cited by 10
Sharma, Y., Sumanadasa, S., Shahi, R., Woodman, R. J., Mangoni, A. A., Bihari, S., & Thompson, C. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-62571-5 · Cited by 12
Immunmodulation durch Ernährung bei kritisch kranken Patienten
Hirschberger, S., Schmid, A., & Kreth, S. (2023) · Die Anaesthesiologie · doi:10.1007/s00101-023-01258-4 · Cited by 9
Yoshida, M., Yamamoto, R., Izumino, H., Matsushima, S., Takatani, Y., Hatakeyama, J., Nakanishi, N., Watanabe, S., Taguchi, A., Kano, K., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.07.021 · Cited by 8
Supplementierung von Vitamin C und D bei kritisch Kranken
Hill, A., Starchl, C., Dresen, E., Stoppe, C., & Amrein, K. (2023) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-022-00986-6 · Cited by 6
Venkataraman, R., Sprague, S., Ramakrishnan, N., Ramachandran, P., Jayakumar, D., Vijayaraghavan, B. K. T., Margabandhu, S., Ramanathan, Y. V., Adhikari, N. K. J., Lamontagne, F., et al. (2023) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24587 · Cited by 7
Self-citationSun, S., Liu, H., Liang, Q., Yang, Y., Cao, X., & Zheng, B. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1346855 · Cited by 12
Cao, W., Xiong, S., Ji, W., Wei, H., Ma, F., & Mao, L. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00765 · Cited by 8
Bian, L., Wang, X., & Liu, D. (2024) · Journal of Food Measurement & Characterization · doi:10.1007/s11694-024-02457-2 · Cited by 7
Melatonin Exerts Positive Effects on Sepsis Through Various Beneficial Mechanisms
Xu, J., Liang, C., Yao, S., & Wang, F. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s509735 · Cited by 8
Vitamin C in critical illness: end of the story or still a place?
Radke, D. I., Homayr, A. L., Stoppe, C., & Elke, G. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001054 · Cited by 8
The Role of Vitamins in Sepsis: A Narrative Review
Radkowski, P., Gogojewicz, A., Charasna, J., Pilaczyńska-Szczȩśniak, Ł., & Grabarczyk, Ł. (2025) · Nutrients · doi:10.3390/nu17213330 · Cited by 6
Roy, S., Chourasia, P. K., Sangani, V., Errabelli, P. K., Patel, S. S., & Adapa, S. (2023) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096231158954 · Cited by 7
You, S., Kweon, O. J., Jung, S., Baek, M. S., & Kim, W. (2023) · Acute and Critical Care · doi:10.4266/acc.2023.00507 · Cited by 6
“However, the effects of the combination of vitamin C, hydrocortisone, and thiamine (the vitamin C protocol) on clinical outcomes have been inconsistent among previous randomized trials [8-10].”
ResultHemilä, H., & Chalker, E. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1391346 · Cited by 6
“Previously we showed that the abrupt termination of 4-day intravenous vitamin C in the LOVIT trial with 862 sepsis patients explained the harm observed in the participants randomized to the vitamin C group (6, 7).”
BackgroundMethodInfluentialStoiber, A., Hermann, A., Wanka, S.-T., Heinz, G., Speidl, W. S., Hengstenberg, C., Schellongowski, P., Staudinger, T., & Zilberszac, R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123505 · Cited by 6
“The mortality rate for septic shock in this study was high, especially compared to recent mixed severe sepsis and septic shock cohorts, where the rates ranged from 24 to 35% [17–19].”
ResultTrentino, K. M., Shander, A., Gross, I., & Farmer, S. L. (2024) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2024.111441 · Cited by 6
New randomized controlled trials on micronutrients in critical care nutrition: A narrative review
Halim, Z., Huang, Y., Lee, Z., & Lew, C. C. H. (2024) · Nutrition in Clinical Practice · doi:10.1002/ncp.11195 · Cited by 7
Reevaluating vitamin C in sepsis and septic shock: a potential benefit in severe cases?
Alissa, A. S., Alrashed, M. A., Alshaya, A. I., Sulaiman, K. A. A., & Alharbi, S. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1476242 · Cited by 6
“However, this positive outcome is contrary to the finding of the most recent and significant RCT, the LOVIT trail, which used a high weight-based dosing of vitamin C and did not report any mortality benefit (28).”
InfluentialYoung, P. J., Lamontagne, F., & Fujii, T. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06822-x · Cited by 6
Self-citationRedox regulation of defense against bacterial and viral pathogens
Ghezzi, P., & Rubartelli, A. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102339 · Cited by 6
Xiong, Q., Lu, Y., Gu, W., Zhang, Y., Li, A., Cai, S., & Zhou, N. (2024) · Food Chemistry X · doi:10.1016/j.fochx.2024.101528 · Cited by 6
“AsA has diverse biological functions, including the elimination of harmful radicals and toxins, the ability to act as a powerful antioxidant within the human body, and the ability to mediate inflammatory responses through multiple mechanisms (Lamontagne et al., 2022).”
BackgroundFooled by Significance Testing: An Analysis of the LOVIT Vitamin C Trial
Sidebotham, D. A. (2022) · Journal of ExtraCorporeal Technology · doi:10.1051/ject/202254324 · Cited by 6
Micronutrient intake to protect against osteoporosis during and after critical illness
Nair, P., Orford, N. R., & Kerschan‐Schindl, K. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000979 · Cited by 7
“A recent trial (LOVIT) has reported an increased risk of death and organ dysfunction in septic patients [25].”
BackgroundReddy, K., Aggarwal, N. R., Alipanah, N., Annane, D., Antcliffe, D. B., Babalis, D. S., Baillie, J. K., Beane, A., Bos, L. D. J., Burrell, A. J. C., et al. (2025) · Efficacy and Mechanism Evaluation · doi:10.3310/ttnd8896 · Cited by 18
Self-citationChang, W.-H., Yang, S.-H., Shen, H.-F., Hu, T.-Y., & Wu, W.-J. (2025) · Biomedicines · doi:10.3390/biomedicines13122904 · Cited by 5
“For example, high-dose vitamin C therapy (often combined with thiamine and corticosteroids) did not significantly improve organ failure or mortality in multiple RCTs—including the CITRIS-ALI, VITAMINS, VICTAS, and LOVIT trials [31–34].”
Early high-dose vitamin C for out-of-hospital cardiac arrest: the VITaCCA randomized clinical trial
Rozemeijer, S., Dubois, E. A., de Grooth, H., den Uil, C. A., Rettig, T. C. D., Rijpstra, T. A., van den Bogaard, B., van Zanten, Bosman, R. J., Elbers, P., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08492-5 · Cited by 7
Pregernig, A., Held, U., Schläpfer, M., & Beck‐Schimmer, B. (2024) · BMC Medicine · doi:10.1186/s12916-024-03552-3 · Cited by 5
Intravenous vitamin C in critically ill adult patients with burns: An integrative review
Novoa, J., Hardy, G., Aramendi, I., & Manzanares, W. (2025) · Nutrition · doi:10.1016/j.nut.2025.112728 · Cited by 5
The roles of vitamin C in infectious diseases: A comprehensive review
Li, R., Guan, L., Liu, Y., Hu, Z., Liu, J., Li, C., & Min, H. (2025) · Nutrition · doi:10.1016/j.nut.2025.112733 · Cited by 7
Beyond Fluid Therapy: The Role of Vitamin C, Steroids, and Thiamine in Sepsis Management
Idahor, C. O., Ogunfuwa, O., Ogbonna, N., Adigwe, A., & Ogbeide, O. A. (2025) · Cureus · doi:10.7759/cureus.84666 · Cited by 5
“Similarly, the Lessening Organ Dysfunction with Vitamin C (LOVIT) trial reported that high-dose vitamin C monotherapy was not only ineffective but also might be associated with harm in certain subgroups [70].”
Chang, W.-H., Hu, T.-Y., & Kuo, L. (2025) · Life · doi:10.3390/life15081317 · Cited by 5
“PMX-HP is reimbursed by Taiwan’s National Health Insurance (NHI) for refractory septic shock, but standardized protocols and evidence-based selection criteria are lacking, leading to potential variation in real-world utilization [24–28].”
Fighting sepsis: still a long way to go
Machado, F. R., Zampieri, F. G., & Myatra, S. N. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00006-1 · Cited by 5
HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status
Sun, Y., Yang, Y., Ye, Z., & Sun, T. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.04.003 · Cited by 5
“[11] 19] One influential trial was The LOVIT study, [17] which included a total of 872 adult patients with sepsis receiving vasopressors in the ICU and found a higher risk of 28-day mortality or persistent organ dysfunction in the vitamin C-treated group.”
BackgroundJapanese Society of Intensive Care Medicine, Egi, M., & Ogura, H. (2022) · Journal of Intensive Care · doi:10.1186/s40560-022-00641-4 · Cited by 7
“conducted a large multicenter RCT, including 872 septic patients, who required vasopressors, to evaluate the effect of high-dose vitamin C [14].”
Montero-Jodra, A., de la Fuente, M. Á., Gobelli, D., Martín-Fernández, M., Villar, J., Tamayo, E., & Simarro, M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166946 · Cited by 7
Sharma, Y., Sumanadasa, S., Shahi, R., & Thompson, C. H. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082257 · Cited by 5
Association between Vitamin C Deficiency and Mortality in Patients with Septic Shock
Park, J. E., Shin, T. G., Jeong, D., Lee, G. T., Ryoo, S. M., Kim, W. Y., Jo, Y. H., Suh, G. J., & Hwang, S. Y. (2022) · Biomedicines · doi:10.3390/biomedicines10092090 · Cited by 7
“In contrast, a recently published large-scale randomized controlled trial (LOVIT trial) of adults with sepsis receiving vasopressor treatment in the ICU found that the composite of death, continued vasopressor requirement, mechanical ventilation, or renal-replacement therapy on day 28 was significantly higher in those…”
ResultBlood microbial signatures associated with mortality in patients with sepsis: A pilot study
Chen, H., Liu, W., Coker, O. O., Qin, N., Chen, H., Wang, Y., Liu, X., Zhang, L., Choi, G. Y. S., Wong, W. T., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29572 · Cited by 4
“…Sequential Organ Failure Assessment (qSOFA) score and Acute Physiology and Chronic Health Evaluation (APACHE II) score were recorded accordingly [11] to assess organ failure and disease severity respectively for adult patients admitted to the ICU at Prince of Wales Hospital of The Chinese…”
Vitamin C for patients with sepsis?
Hemilä, H., & Chalker, E. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1450091 · Cited by 4
Mortality in the Sepsis-3 Era: A Systematic Review of Multicenter Randomized Controlled Trials
Nemet, M., Karakuş, İ. S., Gmehlin, C. G., Halpern, G. A., Ghafouri, K., Abramovich, S., Raghu, R., Pastrak, M., Nikravangolsefid, N., Gerberi, D., et al. (2025) · Shock · doi:10.1097/shk.0000000000002687 · Cited by 6
Bishop, M. S., Lane, D. J. R., Ayton, S., May, C. N., Plummer, M. P., & Lankadeva, Y. R. (2026) · Critical Care · doi:10.1186/s13054-025-05831-8 · Cited by 7
“Using the same dosing regimen as CITRUS-ALI, the LOVIT trial compared IV ascorbic acid with placebo in 872 patients with sepsis and a vasopressor requirement [11].”
InfluentialTariq, M. A., Amin, H., & Ali, U. (2022) · Acute and Critical Care · doi:10.4266/acc.2022.01088 · Cited by 4
“The recent publication of results from LOVIT (Less-ening Organ Dysfunction with Vitamin C), the largest trial to date addressing this question, justifies re-examination of the evidence [4].”
Wang, Z., & Pei, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1500734 · Cited by 5
Becker, N., Bülow, J. M., Franz, N., Marzi, İ., Gebhard, F. T., Eguchi, A., Rinderknecht, H., & Relja, B. (2025) · Shock · doi:10.1097/shk.0000000000002626 · Cited by 4
“By stratifying patients at high risk for sepsis, patient enrollment criteria for clinical trials, for example, such as those assessing the efficacy of antioxidative effects of vitamin C therapy (61) could be refined.”
Early, very high-dose, and prolonged vitamin C administration in murine sepsis
Kim, O., Kim, T. W., Kang, H., Jeon, T. J., Chang, E. S., Lee, H. J., & Kim, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-02622-7 · Cited by 5
“In the recent LOVIT trial 36 , vitamin C was administered for only 4 d, and the signal for harm might be due to rebound effects on drug cessation.”
Martín, L. G., de la Hoz, I., Martín, M., Fernández, C., Grande, A. M., Roux, D. P., Villahoz, J., Gómez, M., Espiño, M., Pastor, Ó., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000777 · Cited by 4
“[29,30] However, other authors have argued that these results may be due to abrupt discontinuation of AA rather than the treatment itself.”
Sangla, F., Verissimo, T., Faivre, A., Glauser, T., Cheah, S. K., Assouline, B., Sgardello, S. D., & Legouis, D. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1223862 · Cited by 4
“Moreover, several publications have raised concerns about possible harmful effects associated with high dose vitamin C (13, 18).”
BackgroundMultistudy Research Operations in the ICU: An Interprofessional Pandemic-Informed Approach
Cook, D. J., Duan, E. H., Clarke, F. J., Matic, K., Culgin, S., Kelly, L., Nelson, K., Wallace, C., Soth, M. D., Lewis, K. A., et al. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000808 · Cited by 5
Self-citationRivas, M., Motes, A., Ismail, A., Yang, S., Sotello, D., Arevalo, M., Vutthikraivit, W., Suchartlikitwong, S., Carrasco, C., IWUJI, K. C., et al. (2023) · SAGE Open Medicine · doi:10.1177/20503121221146907 · Cited by 6
Taylor, S. D., Hart, K. A., Vaughn, S. A., Giancola, S. C., Serpa, P. B. S., & dos Santos, A. P. (2023) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16934 · Cited by 4
“35 Recent clinical trials in human sepsis have found that low to moderate ( 50 mg/kg) doses of AA administered IV did not improve outcome, 51 – 54 despite earlier prelimi-nary studies that suggested otherwise.”
BackgroundKalil, A. C., & Simpson, S. Q. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005939 · Cited by 4
Legouis, D., Monard, C., Ourahmoune, A., Sgardello, S. D., Quintard, H., Criton, G., Sangla, F., & Schneider, A. G. (2024) · Critical Care · doi:10.1186/s13054-024-05188-4 · Cited by 3
Ow, C. P. C., Peiris, R. M., Trask-Marino, A. L., Hood, S. G., Betrie, A. H., Lane, D. J. R., Bellomo, R., Plummer, M. P., May, C. N., & Lankadeva, Y. R. (2025) · Critical Care · doi:10.1186/s13054-025-05799-5 · Cited by 7
“Reported outcomes from clinical trials using low-to-moderate doses of ascorbic acid in sepsis have been inconsistent, with many trials showing no significant benefit [8, 9], mild benefit [10–12] or detrimental outcomes [13, 14].”
Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?
Papatheodosiou, D., Giamarellos‐Bourboulis, E. J., & Tsoukas, C. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2646192 · Cited by 3
“Recently, a randomized controlled trial in unselected ICU patients with sepsis reported that vitamin C was associated with higher 28-day mortality and persisting organ dysfunction compared to the placebo [133].”
González-Vázquez, S. A., Gómez-Ramírez, E. E., González-López, L., Gámez-Nava, J. I., Peraza-Zaldívar, J. A., Santiago-Garcia, A. P., Ramírez-Villafaña, M., González-Ponce, F., Gomez-Camarena, J. J., Saldaña-Cruz, A. M., et al. (2024) · Medicina · doi:10.3390/medicina60030464 · Cited by 4
“However, this differs from the results of Lamontagne et al. [7] and Lyu et al. [18], who both found a higher risk of mortality for patients who used IV vitamin C compared to a placebo group (RR: 1.17 and HR: 1.08), but these results were not statistically significant.”
BackgroundResultInfluentialChelly, J., Peres, N., Sboui, G., Maizel, J., Beuzelin, M., Nigeon, O., Préau, S., Vong, L. V., Tamion, F., Lambiotte, F., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087303 · Cited by 3
Silva, S. D., Urwin, A., Grimwood, C. L., Goh, E. K. E., Higgins, A. M., & Hodgson, C. L. (2025) · Critical Care Explorations · doi:10.1097/cce.0000000000001238 · Cited by 8
Lumlertgul, N., Wannakittirat, A., Kung, J. Y. C., Srisawat, N., Collister, D., See, E. J., Pannu, N., Mehta, R. L., Soranno, D. E., Ostermann, M., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04202-y · Cited by 3
Vitamin C Versus Placebo in Pediatric Septic Shock (VITACiPS) - A Randomised Controlled Trial
Sankar, J., Manoharan, A., Lodha, R., Sharma, H. P., & Kabra, S. (2025) · Journal of Intensive Care Medicine · doi:10.1177/08850666251362121 · Cited by 4
“15,25,26”
Why One-Size-Fits-All Doesn’t Work in Intensive Care Unit Nutrition?
Bear, D. E., Lambell, K., & Stoppe, C. (2024) · Critical Care Clinics · doi:10.1016/j.ccc.2024.09.008 · Cited by 3
Kanjee, Z., Berg, K. M., Bell, T. D., & Reynolds, E. E. (2023) · Annals of Internal Medicine · doi:10.7326/m22-3385 · Cited by 4
Huang, Y., Li, P., & Lew, C. C. H. (2023) · Nutrition in Clinical Practice · doi:10.1002/ncp.10982 · Cited by 3
Micronutrient use in critical care: Survey of clinical practice
Cameron, L., Lumlertgul, N., Bear, D. E., Cooney, E., McKenzie, C., & Ostermann, M. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.03.023 · Cited by 3
Intravenous vitamin injections: where is the evidence?
BMJ Publishing Group Ltd (2023) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2023.000006 · Cited by 3
Vitamin C for Patients With COVID-19: More Evidence of Lack of Efficacy in Patients With Sepsis
Jabaley, C. S., & Coopersmith, C. M. (2023) · JAMA · doi:10.1001/jama.2023.18592 · Cited by 3
Concerns with the revised Japanese recommendation for administering vitamin C to septic patients
Hemilä, H., & Chalker, E. (2023) · Journal of Intensive Care · doi:10.1186/s40560-023-00702-2 · Cited by 3
Vitamin C deficiency in critically ill COVID-19 patients admitted to intensive care unit
Chiscano‐Camón, L., Ruiz‐Rodríguez, J. C., Plata-Menchaca, E. P., Martin, L., Bajaña, I., Martin-Rodríguez, C., Palmada, C., Ferrer, R., Camós, S., Villena-Ortiz, Y., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1301001 · Cited by 4
“One of the last reports, the LOVIT trial (56), again showed vitamin C deficiency at the beginning of the study, however concluded that in adults with sepsis receiving vasopressor therapy in the ICU, those who received intravenous vitamin C had a higher risk of death or persistent organ dysfunction…”
BackgroundVasopressor Therapy in the Intensive Care Unit
Li, F., & Wimer, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_50 · Cited by 3
Nutrition in the critically ill patient
Koekkoek, W. A. C. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1675 · Cited by 3
Editorial: Personalized therapy in ARDS, volume II
Battaglini, D., Guérin, C., & Rocco, P. R. M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1533593 · Cited by 4
Acute management of sepsis beyond 24 hours
Premachandra, A., & Heming, N. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0044-1787991 · Cited by 2
Diab, A. M., Stack, H. M., McKeown, B. T., Carleton, B., & Goralski, K. B. (2025) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2024-0055 · Cited by 2
Does nutrition therapy alter the pathophysiology of severe acute pancreatitis?
Gao, L., Xu, Y., & Ke, L. (2025) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001284 · Cited by 2
Das, U. N. (2025) · Nutrition · doi:10.1016/j.nut.2025.112924 · Cited by 3
Vitamin C for sepsis: from mechanisms to individualized therapy
Xiao, Y., Gong, F., Zhang, L., & Gui, C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1700351 · Cited by 2
“More concerningly, the LOVIT trial revealed not only lack of mortality benefit with high-dose vitamin C in septic shock but an increased risk of death or persistent organ dysfunction (73), with no differential effects across inflammatory phenotypes (86).”
Trends in Use of IV Vitamin C Among Patients With Sepsis
Segall, R. E., Lamontagne, F., Vail, E. A., Wunsch, H., Bosch, N. A., Walkey, A. J., Pinto, R. L., Gershengorn, H. B., & Adhikari, N. K. J. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007003 · Cited by 2
Self-citationChang, W.-H., Hu, T.-Y., & Kuo, L. (2026) · Diagnostics · doi:10.3390/diagnostics16010173 · Cited by 2
“…supportive strategies, including intravenous fluid strategies [30], choice of resuscitation targets (e.g., peripheral perfusion-based approaches versus lactate-driven strategies) [31], corticosteroid regimens [32,33], and vitamin C–based interventions with mixed findings across studies [34–36].”
Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches
Prajapati, M., Singh, V., Mishra, A., Khatua, D., Rana, M., & Jyoti, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1810887 · Cited by 4
“However, massive prospective randomized studies have yielded at best mild benefits, and it is possibly harmful to administer the huge doses of vitamin C to patients with sepsis (Lamontagne et al., 2022).”
Hu, J., Zhang, J., Li, D., Hu, X. Y., Li, Q., Wang, W., Su, J., Wu, D., Kang, H., & Zhou, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-54826-y · Cited by 4
“Candidates in the current clinical trials were consist of plenty patients with pulmonary infection 5,6,8,9,11,40 .”
BackgroundResultInfluentialSuárez-de-la-Rica, A., Croes, B., Ciudad, L., Vallejo, I., Mújica, J., Díaz‐Almirón, M., & Maseda, E. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/107.2022 · Cited by 3
It ain't what you do (it's the way that you do it): modulating the host response in sepsis
Millar, J. E., & Docherty, A. B. (2024) · Anaesthesia · doi:10.1111/anae.16314 · Cited by 2
“While patients with sepsis typically exhibit lower vitamin C levels, Mendelian randomisation studies have found no causal link between vitamin C levels and sepsis risk [12], a fi nding consistent with emerging trial evidence [13].”
Simmons, G. L., Sabo, R., Qayyum, R., Aziz, M., Martin, E., Bernard, R. J., Sriparna, M., McIntire, C. A., Krieger, E., Brophy, D. F., et al. (2024) · eJHaem · doi:10.1002/jha2.995 · Cited by 2
Vitamin C in sepsis treatment: Not necessarily beneficial
Shao, Q., & Liu, F. (2025) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-24-00020 · Cited by 2
Metadata
- Authors
- Lamontagne, F., Masse, M.-H., Menard, J., Sprague, S., Pinto, R., Heyland, D. K., Cook, D. J., Battista, M.-C., Day, A. G., Guyatt, G. H., Kanji, S., Parke, R., McGuinness, S. P., Tirupakuzhi Vijayaraghavan, B.-K., Annane, D., Cohen, D., Arabi, Y. M., Bolduc, B., Marinoff, N., Rochwerg, B., Millen, T., Meade, M. O., Hand, L., Watpool, I., Porteous, R., Young, P. J., D’Aragon, F., Belley-Cote, E. P., Carbonneau, E., Clarke, F., Maslove, D. M., Hunt, M., Chassé, M., Lebrasseur, M., Lauzier, F., Mehta, S., Quiroz-Martinez, H., Rewa, O. G., Charbonney, E., Seely, A. J. E., Kutsogiannis, D. J., LeBlanc, R., Mekontso-Dessap, A., Mele, T. S., Turgeon, A. F., Wood, G., Kohli, S. S., Shahin, J., Twardowski, P., & Adhikari, N. K. J.
- Affiliations
- Université de Sherbrooke (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Research Centre of the Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada J1H 5N4
- McMaster University (CA)
- Sunnybrook Health Science Centre (CA)
- Queen's University (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- Ottawa Hospital (CA)
- University of Auckland (NZ)
- Auckland City Hospital (NZ)
- Department of Critical Care Medicine, Apollo Hospitals, Chennai, India
- Inserm (FR)
- Bishop's University (CA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Juravinski Hospital (CA)
- Hamilton Health Sciences (CA)
- Ottawa Hospital Research Institute (CA)
- Apollo Hospitals (IN)
- McMaster University, Department of Medicine, Hamilton, ON, Canada L8N 3Z5
- Centre Hospitalier de l’Université de Montréal (CA)
- Université Laval (CA)
- University of Toronto (CA)
- University of Alberta (CA)
- Hôpital du Sacré-Cœur de Montréal (CA)
- University of Ottawa (CA)
- Université de Sherbrooke, Department of Medicine, Sherbrooke, QC, Canada J1H 5N4
- AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation Creteil, Île-de-France, FR 94000
- Western University (CA)
- Island Health (CA)
- McGill University Health Centre (CA)
- University of Otago, Department of Surgical Sciences, Dunedin, NZ 9054
- ORCID
- Lamontagne, François
- Masse, Marie-Hélène
- Sprague, Sheila
- Pinto, Ruxandra
- Heyland, Daren K.
- Battista, Marie-Claude
- Day, Andrew G.
- Guyatt, Gordon H.
- Kanji, Salmaan
- Parke, Rachael
- McGuinness, Shay P.
- Annane, Djillali
- Cohen, Dian
- Arabi, Yaseen M.
- Rochwerg, Bram
- Meade, Maureen O.
- Watpool, Irene
- Porteous, Rebecca
- Young, Paul J.
- Clarke, France
- Maslove, David M.
- Chassé, Michaël
- Lauzier, François
- Mehta, Sangeeta
- Rewa, Oleksa G.
- Charbonney, Emmanuel
- Seely, Andrew J.E.
- Kutsogiannis, Demetrios J.
- Mele, Tina S.
- Turgeon, Alexis F.
- Wood, Gordon
- Shahin, Jason
- Adhikari, Neill K.J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-06-23
- Volume
- 386
- Issue
- 25
- Pages
- 2387-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4282975062
- Cited by
- 350
- References
- 31
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 75 · 2023: 98 · 2022: 40
- FWCI
- 45.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- The Lotte & John Hecht Memorial Foundation (4318)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- intravenous vitamin C, vitamin C, vasopressor therapy, intensive care unit, mortality, organ dysfunction, acute kidney injury, hypoglycemia, anaphylaxis, sepsis treatment, critically ill adults, health-related quality of life, 6-month survival, biomarkers, organ dysfunction scores
- MeSH terms
- Adult, Ascorbic Acid, Humans, Hypoglycemic Agents, Intensive Care Units, Multiple Organ Failure, Quality of Life, Vasoconstrictor Agents, Vitamins, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.